Delivery Order SPE2DB20D3103-SPE2DB26FL4D8
- Not listed
- The Defense Logistics Agency awarded a $10,153.20 delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with a firm fixed price structure and an ultimate completion date of September 4, 2025. This contract is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The award was made competitively with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,707.52 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. The contract, which is a child order under a larger vehicle, carries a firm fixed price structure with no set-aside designation and was competitively awarded. The ultimate completion date is June 3, 2025, with performance to be fulfilled at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,384.40 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This is a firm fixed-price, competitive award with no set-aside designation, issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,384.40 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- This delivery order, awarded September 14, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Cervidil 10 mg vaginal inserts with a firm fixed price ceiling value of $5,886.42 and an ultimate completion date of September 15, 2025. The contract represents a non-set-aside award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $4,061.28 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This firm fixed-price, non-set-aside contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,030.64 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery order as part of its extensive federal medical procurement portfolio serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Cervidil 10 mg vaginal inserts at a firm fixed price ceiling value of $2,030.64. This is a non-set-aside, competitively awarded contract that will be fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.44 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This contract, awarded on June 6, 2025, with an ultimate completion date of June 9, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, a pharmaceutical product used in obstetric care. This firm fixed-price delivery order, valued at $3,384.40, was competitively awarded without set-aside designation and carries an ultimate completion date of July 30, 2025. The contract was awarded on July 29, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4D8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,061.28 to supply Cervidil 10 mg vaginal inserts, with an ultimate completion date of October 29, 2025. The contract, awarded on October 28, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to supply a broad range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide. The Cervidil order represents a routine pharmaceutical delivery under this established prime vendor relationship, consistent with AmerisourceBergen's extensive portfolio of federal medical supply contracts with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 10/28/25 |